Bile acids as modulators of gut microbiota composition and function

References

• Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 2016;14(8):e1002533. Available from: https://pubmed.ncbi.nlm.nih.gov/27541692/
   PubMed Web of Science ®Google Scholar
• Levy M, Blacher E, Elinav E. Microbiome, metabolites and host immunity. Curr Opin Microbiol. 2017;35:8–27. Available from: https://pubmed.ncbi.nlm.nih.gov/27883933/.
   PubMed Web of Science ®Google Scholar
• Koh A, de Vadder F, Kovatcheva-Datchary P, Bäckhed F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell [Internet] 2016; 165:1332–1345. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27259147
   PubMed Web of Science ®Google Scholar
• Louis P, Hold GL, Flint HJ. The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol [Internet] 2014; 12:661–672. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25198138.
   PubMed Web of Science ®Google Scholar
• McCarville JL, Chen GY, Cuevas VD, Troha K, Ayres JS. Microbiota metabolites in health and disease. Annu Rev Immunol [Internet] 2020; 38:147–170. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32340573.
   PubMed Web of Science ®Google Scholar
• Rooks MG, Garrett WS. Gut microbiota, metabolites and host immunity. Nat Rev Immunol [Internet] 2016; 16:341–352. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27231050.
   PubMed Web of Science ®Google Scholar
• Tong Y, Marion T, Schett G, Luo Y, Liu Y. Microbiota and metabolites in rheumatic diseases. Autoimmun Rev [Internet] 2020; 19:102530. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32240855.
   PubMed Web of Science ®Google Scholar
• Cani PD. Gut microbiota-at the intersection of everything? Nat Rev Gastroenterol Hepatol. 2017;14:321–322.
   PubMed Web of Science ®Google Scholar
• Conlon MA, Bird AR. The impact of diet and lifestyle on gut microbiota and human health. Nutrients [Internet] 2014; 7:17–44. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25545101.
   PubMed Web of Science ®Google Scholar
• Litvak Y, Byndloss MX, Bäumler AJ. Colonocyte metabolism shapes the gut microbiota. Science [Internet] 2018; 362. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30498100
   PubMed Web of Science ®Google Scholar
• Lee J-Y, Tsolis RM, Bäumler AJ. The microbiome and gut homeostasis. Science [Internet] 2022; 377:eabp9960. Available from: http://www.ncbi.nlm.nih.gov/pubmed/35771903
   Web of Science ®Google Scholar
• Litvak Y, Byndloss MX, Tsolis RM, Bäumler AJ. Dysbiotic Proteobacteria expansion: a microbial signature of epithelial dysfunction. Curr Opin Microbiol [Internet] 2017; 39:1–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28783509
   PubMed Web of Science ®Google Scholar
• Shin N-R, Whon TW, Bae J-W. Proteobacteria: microbial signature of dysbiosis in gut microbiota. Trends Biotechnol [Internet] 2015; 33:496–503. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26210164
   PubMed Web of Science ®Google Scholar
• Johansson ME, Phillipson M, Petersson J, Velcich A, Holm L, Hansson GC. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc Natl Acad Sci U S A [Internet] 2008; 105:15064–15069. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18806221
   PubMed Web of Science ®Google Scholar
• Johansson ME v, Gustafsson JK, Sjöberg KE, Petersson J, Holm L, Sjövall H, Hansson GC. Bacteria penetrate the inner mucus layer before inflammation in the dextran sulfate colitis model. PLoS One [Internet]. 2010;5. e12238. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20805871
   PubMed Web of Science ®Google Scholar
• van der Post S, Jabbar KS, Birchenough G, Arike L, Akhtar N, Sjovall H, Johansson ME, Hansson GC. Structural weakening of the colonic mucus barrier is an early event in ulcerative colitis pathogenesis. Gut [Internet] 2019; 68:2142–2151. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30914450
   PubMed Web of Science ®Google Scholar
• Johansson ME, Gustafsson JK, Holmén-Larsson J, Jabbar KS, Xia L, Xu H, Ghishan FK, Carvalho FA, Gewirtz AT, Sjövall H, et al. Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis. Gut [Internet] 2014; 63:281–291. Available from: https://gut.bmj.com/lookup/doi/10.1136/gutjnl-2012-303207
   PubMed Web of Science ®Google Scholar
• Staley C, Weingarden AR, Khoruts A, Sadowsky MJ. Interaction of gut microbiota with bile acid metabolism and its influence on disease states. Appl Microbiol Biotechnol [Internet] 2017; 101:47–64. Available from: http://link.springer.com/10.1007/s00253-016-8006-6
   PubMed Web of Science ®Google Scholar
• Chiang JYL. Bile acid metabolism and signaling. Compr Physiol [Internet] 2013; 3:1191–1212. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23897684
   PubMed Web of Science ®Google Scholar
• Bustos AY, Font de Valdez G, Fadda S, Taranto MP. New insights into bacterial bile resistance mechanisms: the role of bile salt hydrolase and its impact on human health. Food Res Int [Internet] 2018; 112:250–262. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30131136
   PubMed Web of Science ®Google Scholar
• Ghosh S, Whitley CS, Haribabu B, Jala VR. Regulation of intestinal barrier function by microbial metabolites. Cell Mol Gastroenterol Hepatol [Internet] 2021; 11:1463–1482. Available from http://www.ncbi.nlm.nih.gov/pubmed/33610769
   PubMed Web of Science ®Google Scholar
• Chang P. Chemical mechanisms of colonization resistance by the gut microbial metabolome. ACS Chem Biol [Internet] 2020; 15:1119–1126. Available from: http://www.ncbi.nlm.nih.gov/pubmed/31895538
   PubMed Web of Science ®Google Scholar
• Romain G, Tremblay S, Arena ET, Antunes LCM, Covey S, Chow MT, Finlay BB, Menendez A. Enterohepatic bacterial infections dysregulate the FGF15-FGFR4 endocrine axis. BMC Microbiol [Internet] 2013; 13:238.Available from: http://www.ncbi.nlm.nih.gov/pubmed/24165751
   PubMed Web of Science ®Google Scholar
• Uribe JH, Collado-Romero M, Zaldívar-López S, Arce C, Bautista R, Carvajal A, Cirera S, Claros MG, Garrido JJ. Transcriptional analysis of porcine intestinal mucosa infected with Salmonella Typhimurium revealed a massive inflammatory response and disruption of bile acid absorption in ileum. Vet Res [Internet] 2016; 47:11.Available from: http://www.veterinaryresearch.org/content/47/1/11
   PubMed Web of Science ®Google Scholar
• Stacy A, Andrade-Oliveira V, McCulloch JA, Hild B, Oh JH, Perez-Chaparro PJ, Sim CK, Lim AI, Link VM, Enamorado M, et al. Infection trains the host for microbiota-enhanced resistance to pathogens. Cell [Internet] 2021; 184:615–627. Available from: http://www.ncbi.nlm.nih.gov/pubmed/33453153
   PubMed Web of Science ®Google Scholar
• Li J, Dawson PA. Animal models to study bile acid metabolism. Biochim Biophys Acta Mol Basis Dis [Internet] 2019; 1865:895–911. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29782919
   PubMed Web of Science ®Google Scholar
• Sayin SI, Wahlström A, Felin J, Jäntti S, Marschall H-U, Bamberg K, Angelin B, Hyötyläinen T, Orešič M, Bäckhed F. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab [Internet] 2013; 17:225–235. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23395169
   PubMed Web of Science ®Google Scholar
• Macdonald IA, White BA, Hylemon PB. Separation of 7 alpha- and 7 beta-hydroxysteroid dehydrogenase activities from clostridium absonum ATCC# 27555 and cellular response of this organism to bile acid inducers. J Lipid Res [Internet] 1983; 24:1119–1126. Available from: http://www.ncbi.nlm.nih.gov/pubmed/6579144
   PubMed Web of Science ®Google Scholar
• Ridlon JM, Bajaj JS. The human gut sterolbiome: bile acid-microbiome endocrine aspects and therapeutics. Acta Pharm Sin B [Internet] 2015; 5:99–105. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26579434
   PubMed Web of Science ®Google Scholar
• Jones B, Begley M, Hill C, Gahan CGM, Marchesi JR. Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome. Proceedings of the National Academy of Sciences [Internet] 2008; 105:13580–13585. Available from: https://pnas.org/doi/full/10.1073/pnas.0804437105
   PubMed Web of Science ®Google Scholar
• Doden HL, Ridlon JM. Microbial Hydroxysteroid dehydrogenases: from alpha to omega. Microorganisms [Internet] 2021; 9:469.Available from: https://www.mdpi.com/2076-2607/9/3/469
   PubMed Web of Science ®Google Scholar
• Dawson PA, Karpen SJ. Intestinal transport and metabolism of bile acids. J Lipid Res [Internet] 2015; 56:1085–1099. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25210150
   PubMed Web of Science ®Google Scholar
• Alnouti Y. Bile Acid sulfation: a pathway of bile acid elimination and detoxification. Toxicol Sci [Internet] 2009; 108:225–246. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19131563
   PubMed Web of Science ®Google Scholar
• Quinn RA, Melnik A, Vrbanac A, Fu T, Patras KA, Christy MP, Bodai Z, Belda-Ferre P, Tripathi A, Chung LK, et al. Global chemical effects of the microbiome include new bile-acid conjugations. Nature [Internet] 2020; 579:123–129. Available from http://www.ncbi.nlm.nih.gov/pubmed/32103176
   PubMed Web of Science ®Google Scholar
• Kliewer SA, Mangelsdorf DJ. Bile acids as hormones: the FXR-FGF15/19 pathway. Dig Dis [Internet] 2015; 33:327–331. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26045265
   PubMed Web of Science ®Google Scholar
• Fiorucci S, Carino A, Baldoni M, Santucci L, Costanzi E, Graziosi L, Distrutti E, Biagioli M. Bile Acid signaling in inflammatory bowel diseases. Dig Dis Sci [Internet] 2021; 66:674–693. Available from: http://www.ncbi.nlm.nih.gov/pubmed/33289902
   PubMed Web of Science ®Google Scholar
• Shiffka SJ, Kane MA, Swaan PW. Planar bile acids in health and disease. Biochimica et Biophysica Acta (BBA) - Biomembranes [Internet] 2017; 1859:2269–2276. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0005273617302699
   PubMed Web of Science ®Google Scholar
• Jiang L, Zhang H, Xiao D, Wei H, Chen Y. Farnesoid X receptor (FXR): structures and ligands. Comput Struct Biotechnol J [Internet] 2021; 19:2148–2159. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2001037021001410
   PubMed Web of Science ®Google Scholar
• Tipton L, Darcy JL, Hynson NA. A developing symbiosis: enabling cross-talk between ecologists and microbiome scientists. Front Microbiol. [Internet] 2019; 10. Available from https://www.frontiersin.org/article/10.3389/fmicb.2019.00292/full
   PubMed Web of Science ®Google Scholar
• Berg G, Rybakova D, Fischer D, Cernava T, Vergès M-CC, Charles T, Chen X, Cocolin L, Eversole K, Corral GH, et al. Microbiome definition re-visited: old concepts and new challenges. Microbiome [Internet] 2020; 8:103.Available from: http://www.ncbi.nlm.nih.gov/pubmed/32605663
   PubMed Web of Science ®Google Scholar
• Ridlon JM, Harris SC, Bhowmik S, Kang D-J, Hylemon PB. Consequences of bile salt biotransformations by intestinal bacteria. Gut Microbes [Internet] 2016; 7:22–39. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26939849
   PubMed Web of Science ®Google Scholar
• Paik D, Yao L, Zhang Y, Bae S, D’Agostino GD, Zhang M, Kim E, Franzosa EA, Avila-Pacheco J, Bisanz JE, et al. Human gut bacteria produce ΤΗ17-modulating bile acid metabolites. Nature [Internet] 2022; 603:907–912. Available from: http://www.ncbi.nlm.nih.gov/pubmed/35296854
   PubMed Web of Science ®Google Scholar
• Li W, Hang S, Fang Y, Bae S, Zhang Y, Zhang M, Wang G, McCurry MD, Bae M, Paik D, et al. A bacterial bile acid metabolite modulates Treg activity through the nuclear hormone receptor NR4A1. Cell Host Microbe [Internet] 2021; 29:1366–1377. Available from: http://www.ncbi.nlm.nih.gov/pubmed/34416161
   PubMed Web of Science ®Google Scholar
• Eyssen H, de Pauw G, Stragier J, Verhulst A. Cooperative formation of omega-muricholic acid by intestinal microorganisms. Appl Environ Microbiol [Internet] 1983; 45:141–147. Available from: http://www.ncbi.nlm.nih.gov/pubmed/6824314
   PubMed Web of Science ®Google Scholar
• Degirolamo C, Rainaldi S, Bovenga F, Murzilli S, Moschetta A. Microbiota modification with probiotics induces hepatic bile acid synthesis via downregulation of the Fxr-Fgf15 axis in mice. Cell Rep [Internet] 2014; 7:12–18. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24656817
   PubMed Web of Science ®Google Scholar
• Madsen D, Beaver M, Chang L, Bruckner-Kardoss E, Wostmann B. Analysis of bile acids in conventional and germfree rats. J Lipid Res [Internet] 1976; 17:107–111. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1270929
   PubMed Web of Science ®Google Scholar
• Nishida A, Inoue R, Inatomi O, Bamba S, Naito Y, Andoh A. Gut microbiota in the pathogenesis of inflammatory bowel disease. Clin J Gastroenterol [Internet] 2018; 11:1–10. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29285689
   PubMed Web of Science ®Google Scholar
• Duboc H, Rainteau D, Rajca S, Humbert L, Farabos D, Maubert M, Grondin V, Jouet P, Bouhassira D, Seksik P, et al. Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol Motil [Internet] 2012; 24:513–520. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22356587
   PubMed Web of Science ®Google Scholar
• Duboc H, Rajca S, Rainteau D, Benarous D, Maubert M-A, Quervain E, Thomas G, Barbu V, Humbert L, Despras G, et al. Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases. Gut [Internet] 2013; 62:531–539. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22993202
   PubMed Web of Science ®Google Scholar
• Franzosa EA, Sirota-Madi A, Avila-Pacheco J, Fornelos N, Haiser HJ, Reinker S, Vatanen T, Hall AB, Mallick H, McIver LJ, et al. Gut microbiome structure and metabolic activity in inflammatory bowel disease. Nat Microbiol [Internet] 2019; 4:293–305. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30531976
   PubMed Web of Science ®Google Scholar
• Lloyd-Price J, Arze C, Ananthakrishnan AN, Schirmer M, Avila-Pacheco J, Poon TW, Andrews E, Ajami NJ, Bonham KS, Brislawn CJ, et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature [Internet] 2019; 569:655–662. Available from: http://www.ncbi.nlm.nih.gov/pubmed/31142855
   PubMed Web of Science ®Google Scholar
• Jacobs JP, Goudarzi M, Singh N, Tong M, McHardy IH, Ruegger P, Asadourian M, Moon B-H, Ayson A, Borneman J, et al. A Disease-associated microbial and metabolomics state in relatives of pediatric inflammatory bowel disease patients. Cell Mol Gastroenterol Hepatol [Internet] 2016; 2:750–766. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28174747
   PubMed Web of Science ®Google Scholar
• Wang Y, Gao X, Zhang X, Xiao F, Hu H, Li X, Dong F, Sun M, Xiao Y, Ge T, et al. Microbial and metabolic features associated with outcome of infliximab therapy in pediatric Crohn’s disease. Gut Microbes [Internet] 2021; 13:1–18. Available from: http://www.ncbi.nlm.nih.gov/pubmed/33430702
   PubMed Web of Science ®Google Scholar
• Labbé A, Ganopolsky JG, Martoni CJ, Prakash S, Jones ML. Bacterial bile metabolising gene abundance in Crohn’s, ulcerative colitis and type 2 diabetes metagenomes. PLoS One [Internet] 2014; 9:e115175. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25517115
   PubMed Web of Science ®Google Scholar
• Jia B, Park D, Hahn Y, Jeon CO. Metagenomic analysis of the human microbiome reveals the association between the abundance of gut bile salt hydrolases and host health. Gut Microbes [Internet] 2020; 11:1300–1313. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32329665
   PubMed Web of Science ®Google Scholar
• Ahn J, Sinha R, Pei Z, Dominianni C, Wu J, Shi J, Goedert JJ, Hayes RB, Yang L. Human gut microbiome and risk for colorectal cancer. J Natl Cancer Inst [Internet] 2013; 105:1907–1911. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24316595
   PubMed Web of Science ®Google Scholar
• Selwyn FP, Csanaky IL, Zhang Y, Klaassen CD. Importance of large intestine in regulating bile acids and glucagon-like peptide-1 in germ-free mice. Drug Metab Dispos [Internet] 2015; 43:1544–1556. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26199423
   PubMed Web of Science ®Google Scholar
• Li F, Jiang C, Krausz KW, Li Y, Albert I, Hao H, Fabre KM, Mitchell JB, Patterson AD, Gonzalez FJ. Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity. Nat Commun [Internet] 2013; 4:2384. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24064762
   PubMed Web of Science ®Google Scholar
• Wilson A, Almousa A, Teft WA, Kim RB. Attenuation of bile acid-mediated FXR and PXR activation in patients with Crohn’s disease. Sci Rep [Internet] 2020; 10:1866. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32024859
   PubMed Web of Science ®Google Scholar
• Inagaki T, Moschetta A, Lee Y-K, Peng L, Zhao G, Downes M, Yu RT, Shelton JM, Richardson JA, Repa JJ, et al. Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. Proc Natl Acad Sci U S A [Internet] 2006; 103:3920–3925. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16473946
   PubMed Web of Science ®Google Scholar
• Lorenzo-Zúñiga V, Bartolí R, Planas R, Hofmann AF, Viñado B, Hagey LR, Hernández JM, Mañé J, Alvarez MA, Ausina V, et al. Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats. Hepatology [Internet] 2003; 37:551–557. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12601352
   PubMed Web of Science ®Google Scholar
• Clements WD, Parks R, Erwin P, Halliday MI, Barr J, Rowlands BJ. Role of the gut in the pathophysiology of extrahepatic biliary obstruction. Gut [Internet] 1996; 39:587–593. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8944570
   PubMed Web of Science ®Google Scholar
• van Best N, Rolle-Kampczyk U, Schaap FG, Basic M, Swm OD, Bleich A, Savelkoul PHM, von Bergen M, Penders J, Hornef MW. Bile acids drive the newborn’s gut microbiota maturation. Nat Commun [Internet] 2020; 11:3692. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32703946
   PubMed Web of Science ®Google Scholar
• Islam KBMS, Fukiya S, Hagio M, Fujii N, Ishizuka S, Ooka T, Ogura Y, Hayashi T, Yokota A. Bile Acid Is a Host Factor That Regulates the Composition of the Cecal Microbiota in Rats. Gastroenterology [Internet] 2011; 141:1773–1781. Available from: https://linkinghub.elsevier.com/retrieve/pii/S001650851101081X
   PubMed Web of Science ®Google Scholar
• Tian Y, Gui W, Koo I, Smith PB, Allman EL, Nichols RG, Rimal B, Cai J, Liu Q, Patterson AD. The microbiome modulating activity of bile acids. Gut Microbes [Internet] 2020; 11:979–996. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32138583
   PubMed Web of Science ®Google Scholar
• Xu M, Cen M, Shen Y, Zhu Y, Cheng F, Tang L, Hu W, Dai N. Deoxycholic acid-induced gut dysbiosis disrupts bile acid enterohepatic circulation and promotes intestinal inflammation. Dig Dis Sci [Internet] 2021; 66:568–576. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32198567
   PubMed Web of Science ®Google Scholar
• Friedman ES, Li Y, Shen T-CD, Jiang J, Chau L, Adorini L, Babakhani F, Edwards J, Shapiro D, Zhao C, et al. FXR-dependent modulation of the human small intestinal microbiome by the bile acid derivative obeticholic acid. Gastroenterology [Internet] 2018; 155:1741–1752. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30144429
   PubMed Web of Science ®Google Scholar
• Fiorucci S, Biagioli M, Zampella A, Distrutti E. Bile Acids activated receptors regulate innate immunity. Front Immunol [Internet] 2018; 9:1853. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30150987
   PubMed Web of Science ®Google Scholar
• Suzuki T, Hara H. Dietary fat and bile juice, but not obesity, are responsible for the increase in small intestinal permeability induced through the suppression of tight junction protein expression in LETO and OLETF rats. Nutr Metab (Lond) [Internet] 2010; 7:19.Available from: http://nutritionandmetabolism.biomedcentral.com/articles/10.1186/1743-7075-7-19
   PubMed Web of Science ®Google Scholar
• Murakami Y, Tanabe S, Suzuki T. High-fat diet-induced intestinal hyperpermeability is associated with increased bile acids in the large intestine of mice. J Food Sci [Internet] 2016; 81:H216–22. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26595891
   PubMed Web of Science ®Google Scholar
• de Diego-Cabero N, Mereu A, Menoyo D, Holst JJ, Ipharraguerre IR. Bile acid mediated effects on gut integrity and performance of early-weaned piglets. BMC Vet Res [Internet] 2015; 11:111.Available from: http://www.ncbi.nlm.nih.gov/pubmed/25972097
   PubMed Web of Science ®Google Scholar
• Verbeke L, Farre R, Verbinnen B, Covens K, Vanuytsel T, Verhaegen J, Komuta M, Roskams T, Chatterjee S, Annaert P, et al. The FXR agonist obeticholic acid prevents gut barrier dysfunction and bacterial translocation in cholestatic rats. Am J Pathol [Internet] 2015; 185:409–419. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25592258
   PubMed Web of Science ®Google Scholar
• Gadaleta RM, van Erpecum KJ, Oldenburg B, Willemsen ECL, Renooij W, Murzilli S, Klomp LWJ, Siersema PD, Schipper MEI, Danese S, et al. Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease. Gut [Internet] 2011; 60:463–472. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21242261
   PubMed Web of Science ®Google Scholar
• Cipriani S, Mencarelli A, Chini MG, Distrutti E, Renga B, Bifulco G, Baldelli F, Donini A, Fiorucci S. The bile acid receptor GPBAR-1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitis. PLoS One. 2011;6(10):e25637. https://pubmed.ncbi.nlm.nih.gov/22046243/
   PubMed Web of Science ®Google Scholar
• Lajczak-McGinley NK, Porru E, Fallon CM, Smyth J, Curley C, McCarron PA, Tambuwala MM, Roda A, Keely SJ. The secondary bile acids, ursodeoxycholic acid and lithocholic acid, protect against intestinal inflammation by inhibition of epithelial apoptosis. Physiol Rep [Internet] 2020; 8:e14456. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32562381
   PubMed Web of Science ®Google Scholar
• Terc J, Hansen A, Alston L, Hirota SA. Pregnane X receptor agonists enhance intestinal epithelial wound healing and repair of the intestinal barrier following the induction of experimental colitis. Eur J Pharm Sci [Internet] 2014; 55:12–19. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24486481
   PubMed Web of Science ®Google Scholar
• Dossa AY, Escobar O, Golden J, Frey MR, Ford HR, Gayer CP. Bile acids regulate intestinal cell proliferation by modulating EGFR and FXR signaling. Am J Physiol Gastrointest Liver Physiol [Internet] 2016; 310:G81–92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26608185
   PubMed Web of Science ®Google Scholar
• Xu J, Huang D, Xu X, Wu X, Liu L, Niu W, Lu L, Zhou H. An elevated deoxycholic acid level induced by high-fat feeding damages intestinal stem cells by reducing the ileal IL-22. Biochem Biophys Res Commun [Internet] 2021; 579:153–160. Available from http://www.ncbi.nlm.nih.gov/pubmed/34601200
   PubMed Web of Science ®Google Scholar
• Tremblay S, Romain G, Roux M, Chen X-L, Brown K, Gibson DL, Ramanathan S, Menendez A. Bile Acid Administration Elicits an Intestinal Antimicrobial Program and Reduces the Bacterial Burden in Two Mouse Models of Enteric Infection. Infect Immun [Internet] 2017; 85. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28348052
   Google Scholar
• Zhou H, Zhou S-Y, Gillilland M, Li J-Y, Lee A, Gao J, Zhang G, Xu X, Owyang C. Bile acid toxicity in Paneth cells contributes to gut dysbiosis induced by high-fat feeding. JCI Insight [Internet] 2020; 5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/33055426
   Web of Science ®Google Scholar
• Liu T-C, Kern JT, Jain U, Sonnek NM, Xiong S, Simpson KF, VanDussen KL, Winkler ES, Haritunians T, Malique A, et al. Western diet induces Paneth cell defects through microbiome alterations and farnesoid X receptor and type I interferon activation. Cell Host Microbe [Internet] 2021; 29:988–1001. Available from: http://www.ncbi.nlm.nih.gov/pubmed/34010595
   PubMed Web of Science ®Google Scholar
• Gadaleta RM, Garcia-Irigoyen O, Cariello M, Scialpi N, Peres C, Vetrano S, Fiorino G, Danese S, Ko B, Luo J, et al. Fibroblast Growth Factor 19 modulates intestinal microbiota and inflammation in presence of Farnesoid X Receptor. EBioMedicine [Internet] 2020; 54:102719. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32259714
   PubMed Web of Science ®Google Scholar
• Sorrentino G, Perino A, Yildiz E, El Alam G, Bou SM, Gioiello A, Pellicciari R, Schoonjans K. Bile Acids Signal via TGR5 to Activate Intestinal Stem Cells and Epithelial Regeneration. Gastroenterology [Internet] 2020; 159:956–968. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32485177
   PubMed Web of Science ®Google Scholar
• Lajczak NK, Saint‐Criq V, O’Dwyer AM, Perino A, Adorini L, Schoonjans K, Keely SJ. Bile acids deoxycholic acid and ursodeoxycholic acid differentially regulate human β‐defensin‐1 and ‐2 secretion by colonic epithelial cells. The FASEB J [Internet] 2017; 31:3848–3857. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1096/fj.201601365R
   PubMed Web of Science ®Google Scholar
• Makishima M, Lu TT, Xie W, Whitfield GK, Domoto H, Evans RM, Haussler MR, Mangelsdorf DJ. Vitamin D receptor as an intestinal bile acid sensor. Science [Internet] 2002; 296:1313–1316. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12016314.
   PubMed Web of Science ®Google Scholar
• Ichikawa R, Takayama T, Yoneno K, Kamada N, Kitazume MT, Higuchi H, Matsuoka K, Watanabe M, Itoh H, Kanai T, et al. Bile acids induce monocyte differentiation toward interleukin-12 hypo-producing dendritic cells via a TGR5-dependent pathway. Immunology [Internet] 2012; 136:153–162. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22236403
   PubMed Web of Science ®Google Scholar
• Biagioli M, Carino A, Cipriani S, Francisci D, Marchianò S, Scarpelli P, Sorcini D, Zampella A, Fiorucci S. The bile acid receptor GPBAR1 regulates the M1/M2 Phenotype of intestinal macrophages and activation of GPBAR1 rescues mice from murine colitis. J Immunol [Internet] 2017; 199:718–733. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28607110
   PubMed Web of Science ®Google Scholar
• Yang Z, Koehler AN, Wang L. A novel small molecule activator of nuclear receptor SHP inhibits HCC Cell migration via suppressing Ccl2. Mol Cancer Ther. [Internet] 2016; 15:2294301. Available from: .2294301. Available from: .http://www.ncbi.nlm.nih.gov/pubmed/27486225
   Web of Science ®Google Scholar
• Vavassori P, Mencarelli A, Renga B, Distrutti E, Fiorucci S. The bile acid receptor FXR is a modulator of intestinal innate immunity. J Immunol [Internet] 2009; 183:6251–6261. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19864602
   PubMed Web of Science ®Google Scholar
• Shah YM, Ma X, Morimura K, Kim I, Gonzalez FJ. Pregnane X receptor activation ameliorates DSS-induced inflammatory bowel disease via inhibition of NF-kappaB target gene expression. Am J Physiol Gastrointest Liver Physiol [Internet] 2007; 292:G1114–22. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17170021
   PubMed Web of Science ®Google Scholar
• Liu W, Chen Y, Golan MA, Annunziata ML, Du J, Dougherty U, Kong J, Musch M, Huang Y, Pekow J, et al. Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis. J Clin Invest [Internet] 2013; 123:3983–3996. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23945234
   PubMed Web of Science ®Google Scholar
• Hao H, Cao L, Jiang C, Che Y, Zhang S, Takahashi S, Wang G, Gonzalez FJ. Farnesoid X receptor regulation of the NLRP3 inflammasome underlies cholestasis-associated sepsis. Cell Metab [Internet] 2017; 25:856–867. Available from http://www.ncbi.nlm.nih.gov/pubmed/28380377
   PubMed Web of Science ®Google Scholar
• Yang C-S, Kim J-J, Kim TS, Lee PY, Kim SY, Lee H-M, Shin D-M, Nguyen LT, Lee M-S, Jin HS, et al. Small heterodimer partner interacts with NLRP3 and negatively regulates activation of the NLRP3 inflammasome. Nat Commun [Internet] 2015; 6:6115. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25655831
   PubMed Web of Science ®Google Scholar
• Guo C, Xie S, Chi Z, Zhang J, Liu Y, Zhang L, Zheng M, Zhang X, Xia D, Ke Y, et al. Bile Acids Control Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome. Immunity pInternet] 2016; 45:802–816. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27692610
   PubMed Web of Science ®Google Scholar
• Chen Y, Le TH, Du Q, Zhao Z, Liu Y, Zou J, Hua W, Liu C, Zhu Y. Genistein protects against DSS-induced colitis by inhibiting NLRP3 inflammasome via TGR5-cAMP signaling. Int Immunopharmacol [Internet] 2019; 71:144–154. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30901677
   PubMed Web of Science ®Google Scholar
• Haselow K, Bode JG, Wammers M, Ehlting C, Keitel V, Kleinebrecht L, Schupp A-K, Häussinger D, Graf D. Bile acids PKA-dependently induce a switch of the IL-10/IL-12 ratio and reduce proinflammatory capability of human macrophages. J Leukoc Biol [Internet] 2013; 94:1253–1264. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23990628.
   PubMed Web of Science ®Google Scholar
• Pols TWH, Puchner T, Korkmaz HI, Vos M, Soeters MR, de Vries CJM. Lithocholic acid controls adaptive immune responses by inhibition of Th1 activation through the Vitamin D receptor. PLoS One. 2017;12(5):e0176715. https://pubmed.ncbi.nlm.nih.gov/28493883/.
   PubMed Web of Science ®Google Scholar
• Campbell C, McKenney PT, Konstantinovsky D, Isaeva OI, Schizas M, Verter J, Mai C, Jin W-B, Guo C-J, Violante S, et al. Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells. Nature [Internet] 2020; 581:475–479. Available from:. ;(7809):. http://www.ncbi.nlm.nih.gov/pubmed/32461639
   PubMed Web of Science ®Google Scholar
• Song X, Sun X, Oh SF, Wu M, Zhang Y, Zheng W, Geva-Zatorsky N, Jupp R, Mathis D, Benoist C, et al. Microbial bile acid metabolites modulate gut RORγ+ regulatory T cell homeostasis. Nature [Internet] 2020; 577:410–415. Available from: http://www.ncbi.nlm.nih.gov/pubmed/31875848
   PubMed Web of Science ®Google Scholar
• Hang S, Paik D, Yao L, Kim E, Trinath J, Lu J, Ha S, Nelson BN, Kelly SP, Wu L, et al. Bile acid metabolites control TH17 and Treg cell differentiation. Nature [Internet] 2019; 576:143–148. Available from: http://www.ncbi.nlm.nih.gov/pubmed/31776512
   PubMed Web of Science ®Google Scholar
• Mickael ME, Bhaumik S, Basu R. Retinoid-related orphan receptor RORγt in CD4+ T-cell–mediated intestinal homeostasis and inflammation. Am J Pathol [Internet] 2020; 190:1984–1999. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32735890
   PubMed Web of Science ®Google Scholar
• Cao W, Kayama H, Chen ML, Delmas A, Sun A, Kim SY, Rangarajan ES, McKevitt K, Beck AP, Jackson CB, et al. The xenobiotic transporter Mdr1 enforces T Cell homeostasis in the presence of intestinal bile acids. Immunity [Internet] 2017; 47:1182–1196. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29262351
   PubMed Web of Science ®Google Scholar
• Foley SE, Tuohy C, Dunford M, Grey MJ, de Luca H, Cawley C, Szabady RL, Maldonado-Contreras A, Houghton JM, Ward D, et al. Gut microbiota regulation of P-glycoprotein in the intestinal epithelium in maintenance of homeostasis. Microbiome [Internet] 2021; 9:183.Available from: http://www.ncbi.nlm.nih.gov/pubmed/34493329
   PubMed Web of Science ®Google Scholar
• Mohammed AD, Mohammed Z, Roland MM, Chatzistamou I, Jolly A, Schoettmer LM, Arroyo M, Kakar K, Tian Y, Patterson A, et al. Defective humoral immunity disrupts bile acid homeostasis which promotes inflammatory disease of the small bowel. Nat Commun [Internet] 2022; 13:525.Available from: http://www.ncbi.nlm.nih.gov/pubmed/35082296
   PubMed Web of Science ®Google Scholar
• Sinha SR, Haileselassie Y, Nguyen LP, Tropini C, Wang M, Becker LS, Sim D, Jarr K, Spear ET, Singh G, et al. Dysbiosis-induced secondary bile acid deficiency promotes intestinal inflammation. Cell Host Microbe [Internet] 2020; 27:659–670. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32101703
   PubMed Web of Science ®Google Scholar
• Zhao S, Gong Z, Du X, Tian C, Wang L, Zhou J, Xu C, Chen Y, Cai W, Wu J. Deoxycholic Acid-Mediated Sphingosine-1-Phosphate Receptor 2 Signaling Exacerbates DSS-Induced Colitis through Promoting Cathepsin B Release. J Immunol Res [Internet]. 2018:2481418. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29854830
   PubMed Web of Science ®Google Scholar
• Kang J-H, Kim M, Yim M. FXR/TGR5 mediates inflammasome activation and host resistance to bacterial infection. Biochem Biophys Rep [Internet] 2021; 27:101051. Available from: https://linkinghub.elsevier.com/retrieve/pii/S240558082100145X
   PubMedGoogle Scholar
• Massafra V, Ijssennagger N, Plantinga M, Milona A, Ramos Pittol JM, Boes M, van Mil SWC. Splenic dendritic cell involvement in FXR-mediated amelioration of DSS colitis. Biochim Biophys Acta [Internet] 2016; 1862:166–173. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26554605
   PubMed Web of Science ®Google Scholar
• Xue L-N, Xu K-Q, Zhang W, Wang Q, Wu J, Wang X-Y. Associations between vitamin D receptor polymorphisms and susceptibility to ulcerative colitis and Crohn's disease. Inflamm Bowel Dis [Internet] 2013; 19:54–60. Available from: https://academic.oup.com/ibdjournal/article/19/1/54-60/4602987
   PubMed Web of Science ®Google Scholar
• Yan J, Luo M, Chen Z, He B. The function and role of the Th17/Treg cell balance in inflammatory bowel disease. J Immunol Res [Internet] 2020; 2020:1–8. Available from: https://www.hindawi.com/journals/jir/2020/8813558/
   Web of Science ®Google Scholar
• Rogers AWL, Tsolis RM, Bäumler AJ. Salmonella versus the Microbiome. Microbiol Mol Biol Rev [Internet] 2021; 85. Available from: http://www.ncbi.nlm.nih.gov/pubmed/33361269
   Google Scholar
• Alavi S, Mitchell JD, Cho JY, Liu R, Macbeth JC, Hsiao A. Interpersonal gut microbiome variation drives susceptibility and resistance to cholera infection. Cell [Internet] 2020; 181:1533–1546. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32631492
   PubMed Web of Science ®Google Scholar
• Bachmann V, Kostiuk B, Unterweger D, Diaz-Satizabal L, Ogg S, Pukatzki S, Picardeau M. Bile salts modulate the mucin-activated type VI secretion system of pandemic Vibrio cholerae. PLoS Negl Trop Dis [Internet] 2015; 9:e0004031. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26317760
   PubMed Web of Science ®Google Scholar
• Velazquez EM, Nguyen H, Heasley KT, Saechao CH, Gil LM, Rogers AWL, Miller BM, Rolston MR, Lopez CA, Litvak Y, et al. Endogenous Enterobacteriaceae underlie variation in susceptibility to Salmonella infection. Nat Microbiol [Internet] 2019; 4:1057–1064. Available from: http://www.nature.com/articles/s41564-019-0407-8
   PubMed Web of Science ®Google Scholar
• Liou MJ, Miller BM, Litvak Y, Nguyen H, Natwick DE, Savage HP, Rixon JA, Mahan SP, Hiyoshi H, Rogers AWL, et al. Host cells subdivide nutrient niches into discrete biogeographical microhabitats for gut microbes. Cell Host Microbe [Internet] 2022; 30:836–847. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1931312822002189
   PubMed Web of Science ®Google Scholar
• Behnsen J, Jellbauer S, Wong CP, Edwards RA, George MD, Ouyang W, Raffatellu M. The cytokine IL-22 promotes pathogen colonization by suppressing related commensal bacteria. Immunity [Internet] 2014; 40:262–273. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24508234
   PubMed Web of Science ®Google Scholar
• Guinan J, Villa P, Thangamani S. Secondary bile acids inhibit Candida albicans growth and morphogenesis. Pathog Dis [Internet] 2018; 76. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29648597
   Google Scholar
• Abt MC, McKenney PT, Pamer EG. Clostridium difficile colitis: pathogenesis and host defence. Nat Rev Microbiol [Internet] 2016; 14:609–620. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27573580
   PubMed Web of Science ®Google Scholar
• Kang JD, Myers CJ, Harris SC, Kakiyama G, Lee I-K, Yun B-S, Matsuzaki K, Furukawa M, Min H-K, Bajaj JS, et al. Bile acid 7α-dehydroxylating gut bacteria secrete antibiotics that inhibit Clostridium difficile: role of secondary bile acids. Cell Chem Biol [Internet] 2019; 26:27–34. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30482679
   PubMed Web of Science ®Google Scholar
• Wexler AG, Guiberson ER, Beavers WN, Shupe JA, Washington MK, Lacy DB, Caprioli RM, Spraggins JM, Skaar EP. Clostridioides difficile infection induces a rapid influx of bile acids into the gut during colonization of the host. Cell Rep [Internet] 2021; 36:109683. Available from https://linkinghub.elsevier.com/retrieve/pii/S221112472101130X.
   PubMed Web of Science ®Google Scholar
• Sistrunk JR, Nickerson KP, Chanin RB, Rasko DA, Faherty CS. Survival of the fittest: how bacterial pathogens utilize bile to enhance infection. Clin Microbiol Rev [Internet] 2016; 29:819–836. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27464994
   PubMed Web of Science ®Google Scholar
• Chassaing B, Etienne-Mesmin L, Bonnet R, Darfeuille-Michaud A. Bile salts induce long polar fimbriae expression favouring Crohn’s disease-associated adherent-invasive Escherichia coli interaction with Peyer’s patches. Environ Microbiol [Internet] 2013; 15:355–371. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22789019
   PubMed Web of Science ®Google Scholar
• Vazeille E, Chassaing B, Buisson A, Dubois A, de Vallée A, Billard E, Neut C, Bommelaer G, Colombel J-F, Barnich N, et al. GipA factor supports colonization of peyer’s patches by crohn’s disease-associated Escherichia coli. Inflamm Bowel Dis [Internet] 2016; 22:68–81. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26512715
   PubMed Web of Science ®Google Scholar
• Sevrin G, Massier S, Chassaing B, Agus A, Delmas J, Denizot J, Billard E, Barnich N. Adaptation of adherent-invasive E. coli to gut environment: impact on flagellum expression and bacterial colonization ability. Gut Microbes [Internet] 2020; 11:364–380. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29494278.
   PubMed Web of Science ®Google Scholar
• Ormsby MJ, Logan M, Johnson SA, McIntosh A, Fallata G, Papadopoulou R, Papachristou E, Hold GL, Hansen R, Ijaz UZ, et al. Inflammation associated ethanolamine facilitates infection by Crohn’s disease-linked adherent-invasive Escherichia coli. EBioMedicine [Internet] 2019; 43:325–332. Available from: http://www.ncbi.nlm.nih.gov/pubmed/31036531
   PubMed Web of Science ®Google Scholar
• Delmas J, Gibold L, Faïs T, Batista S, Leremboure M, Sinel C, Vazeille E, Cattoir V, Buisson A, Barnich N, et al. Metabolic adaptation of adherent-invasive Escherichia coli to exposure to bile salts. Sci Rep [Internet] 2019; 9:2175. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30778122
   PubMed Web of Science ®Google Scholar
• Viladomiu M, Metz ML, Lima SF, Jin W-B, Chou L, JRI Live Cell Bank, Guo C-J, Diehl GE, Simpson KW, Scherl EJ, et al. Adherent-invasive E. coli metabolism of propanediol in Crohn’s disease regulates phagocytes to drive intestinal inflammation. Cell Host Microbe. [Internet] 2021; 29:607–619. Available from: http://www.ncbi.nlm.nih.gov/pubmed/33539767
   PubMed Web of Science ®Google Scholar
• Sana TG, Flaugnatti N, Lugo KA, Lam LH, Jacobson A, Baylot V, Durand E, Journet L, Cascales E, Monack DM. Salmonella Typhimurium utilizes a T6SS-mediated antibacterial weapon to establish in the host gut. Proc Natl Acad Sci U S A [Internet] 2016; 113:E5044–51. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27503894.
   PubMed Web of Science ®Google Scholar
• Prouty AM, Gunn JS. Salmonella enterica serovar Typhimurium invasion is repressed in the presence of bile. Infect Immun [Internet] 2000; 68:6763–6769. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11083793
   PubMed Web of Science ®Google Scholar
• Reed AD, Nethery MA, Stewart A, Barrangou R, Theriot CM. Strain-dependent inhibition of Clostridioides difficile by commensal Clostridia carrying the bile acid-inducible (bai) operon. J Bacteriol [Internet] 2020; 202. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32179626
   Web of Science ®Google Scholar
• Theriot CM, Bowman AA, Young VB. Antibiotic-induced alterations of the gut microbiota alter secondary bile acid production and allow for Clostridium difficile spore germination and outgrowth in the large intestine. mSphere. 2016;1(1): e00045–15.
   PubMed Web of Science ®Google Scholar
• Gutierrez D, Weinstock A, Antharam VC, Gu H, Jasbi P, Shi X, Dirks B, Krajmalnik-Brown R, Maldonado J, Guinan J, et al. Antibiotic-induced gut metabolome and microbiome alterations increase the susceptibility to Candida albicans colonization in the gastrointestinal tract. FEMS Microbiol Ecol [Internet] 2020; 96. Available from: http://www.ncbi.nlm.nih.gov/pubmed/31769789
   Google Scholar
• Datta A, Hernandez-Franco JF, Park S, Olson MR, HogenEsch H, Thangamani S. Bile acid regulates mononuclear phagocytes and T Helper 17 Cells to control Candida albicans in the intestine. J Fungi [Internet] 2022; 8:610.Available from: https://www.mdpi.com/2309-608X/8/6/610
   Web of Science ®Google Scholar
• Thangamani S, Monasky R, Lee JK, Antharam V, HogenEsch H, Hazbun TR, Jin Y, Gu H, Guo GL. Bile acid regulates the colonization and dissemination of Candida albicans from the gastrointestinal tract by controlling host defense system and microbiota. J Fungi [Internet] 2021; 7:1030. Available from: https://www.mdpi.com/2309-608X/7/12/1030
   Web of Science ®Google Scholar
• Lebertz H, Andreesen JR. Glycine fermentation by Clostridium histolyticum. Arch Microbiol. [Internet] 1988 [cited 2022 Jul 5]; 150:11–14. Available from: http://link.springer.com/10.1007/BF00409710
   Web of Science ®Google Scholar
• Laue H, Denger K, Cook AM. Taurine reduction in anaerobic respiration of Bilophila wadsworthia RZATAU. Appl Environ Microbiol [Internet] 1997; 63:2016–2021. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9143131
   PubMed Web of Science ®Google Scholar
• Delpino MV, Marchesini MI, Estein SM, Comerci DJ, Cassataro J, Fossati CA, Baldi PC. A bile salt hydrolase of Brucella abortus contributes to the establishment of a successful infection through the oral route in mice. Infect Immun [Internet] 2007; 75:299–305. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17088355
   PubMed Web of Science ®Google Scholar
• Dussurget O, Cabanes D, Dehoux P, Lecuit M, Buchrieser C, Glaser P, Cossart P. European Listeria Genome Consortium. Listeria monocytogenes bile salt hydrolase is a PrfA-regulated virulence factor involved in the intestinal and hepatic phases of listeriosis. Mol Microbiol [Internet] 2002; 45:1095–1106. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12180927
   PubMed Web of Science ®Google Scholar
• O’Flaherty S, Briner Crawley A, Theriot CM, Barrangou R. The Lactobacillus Bile Salt Hydrolase Repertoire Reveals Niche-Specific Adaptation. mSphere [Internet] 2018; 3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29848760
   PubMed Web of Science ®Google Scholar
• Foley MH, O’Flaherty S, Allen G, Rivera AJ, Stewart AK, Barrangou R, Theriot CM. Lactobacillus bile salt hydrolase substrate specificity governs bacterial fitness and host colonization. Proc Natl Acad Sci U S A [Internet] 2021; 118. Available from: http://www.ncbi.nlm.nih.gov/pubmed/33526676
   Web of Science ®Google Scholar
• Huijghebaert SM, Eyssen HJ. Specificity of bile salt sulfatase activity from Clostridium sp. strains S1. Appl Environ Microbiol [Internet] 1982; 44:1030–1034. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7181500
   PubMed Web of Science ®Google Scholar
• van Eldere J, Celis P, de Pauw G, Lesaffre E, Eyssen H. Tauroconjugation of cholic acid stimulates 7 alpha-dehydroxylation by fecal bacteria. Appl Environ Microbiol [Internet] 1996; 62:656–661. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8593067
   PubMed Web of Science ®Google Scholar
• Devkota S, Wang Y, Musch MW, Leone V, Fehlner-Peach H, Nadimpalli A, Antonopoulos DA, Jabri B, Chang EB. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10−/− mice. Nature [Internet] 2012; 487:104–108. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22722865
   PubMed Web of Science ®Google Scholar
• Peck SC, Denger K, Burrichter A, Irwin SM, Balskus EP, Schleheck D. A glycyl radical enzyme enables hydrogen sulfide production by the human intestinal bacterium Bilophila wadsworthia. Proc Natl Acad Sci U S A [Internet] 2019; 116:3171–3176. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30718429
   PubMed Web of Science ®Google Scholar
• Begley M, Gahan CGM, Hill C. The interaction between bacteria and bile. FEMS Microbiol Rev [Internet] 2005; 29:625–651. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16102595
   PubMed Web of Science ®Google Scholar
• Froelich JM, Tran K, Wall D. A pmrA constitutive mutant sensitizes Escherichia coli to deoxycholic acid. J Bacteriol [Internet] 2006; 188:1180–1183. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16428424
   PubMed Web of Science ®Google Scholar
• Murata T, Tseng W, Guina T, Miller SI, Nikaido H. PhoPQ-mediated regulation produces a more robust permeability barrier in the outer membrane of Salmonella enterica serovar Typhimurium. J Bacteriol [Internet] 2007; 189:7213–7222. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17693506
   PubMed Web of Science ®Google Scholar
• Hernández SB, Cava F, Pucciarelli MG, García-Del Portillo F, de Pedro MA, Casadesús J. Bile-induced peptidoglycan remodelling in Salmonella enterica. Environ Microbiol [Internet] 2015; 17:1081–1089. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24762004
   PubMed Web of Science ®Google Scholar
• Crawford RW, Keestra AM, Winter SE, Xavier MN, Tsolis RM, Tolstikov V, Bäumler AJ. Very long O-antigen chains enhance fitness during Salmonella-induced colitis by increasing bile resistance. PLoS Pathog [Internet] 2012; 8:e1002918. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23028318
   PubMed Web of Science ®Google Scholar
• Nikaido H. Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol Biol Rev [Internet] 2003; 67:593–656. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14665678
   PubMed Web of Science ®Google Scholar
• Provenzano D, Klose KE. Altered expression of the ToxR-regulated porins OmpU and OmpT diminishes Vibrio cholerae bile resistance, virulence factor expression, and intestinal colonization. Proc Natl Acad Sci U S A [Internet] 2000; 97:10220–10224. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10944196
   PubMed Web of Science ®Google Scholar
• Zingl FG, Kohl P, Cakar F, Leitner DR, Mitterer F, Bonnington KE, Rechberger GN, Kuehn MJ, Guan Z, Reidl J, et al. Outer membrane vesiculation facilitates surface exchange and in vivo adaptation of Vibrio cholerae. Cell Host Microbe [Internet] 2020; 27:225–237. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1931312819306316
   PubMed Web of Science ®Google Scholar
• Donovan JM, Jackson AA. Transbilayer movement of fully ionized taurine-conjugated bile salts depends upon bile salt concentration, hydrophobicity, and membrane cholesterol content. Biochemistry [Internet] 1997; 36:11444–11451. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9298964
   PubMed Web of Science ®Google Scholar
• Weston N, Sharma P, Ricci V, Piddock LJ. Regulation of the AcrAB-TolC efflux pump in Enterobacteriaceae. Res Microbiol [Internet] 2018; 169:425–431. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29128373
   PubMed Web of Science ®Google Scholar
• Baucheron S, Nishino K, Monchaux I, Canepa S, Maurel M-C, Coste F, Roussel A, Cloeckaert A, Giraud E. Bile-mediated activation of the acrAB and tolC multidrug efflux genes occurs mainly through transcriptional derepression of ramA in Salmonella enterica serovar Typhimurium. J Antimicrob Chemother [Internet] 2014; 69:2400–2406. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24816212
   PubMed Web of Science ®Google Scholar
• Lin J, Sahin O, Michel LO, Zhang Q. Critical role of multidrug efflux pump CmeABC in bile resistance and in vivo colonization of Campylobacter jejuni. Infect Immun [Internet] 2003; 71:4250–4259. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12874300
   PubMed Web of Science ®Google Scholar
• Bina JE, Provenzano D, Wang C, Bina XR, Mekalanos JJ. Characterization of the Vibrio cholerae vexAB and vexCD efflux systems. Arch Microbiol [Internet] 2006; 186:171–181. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16804679
   PubMed Web of Science ®Google Scholar
• Prieto AI, Ramos-Morales F, Casadesús J. Bile-induced DNA damage in Salmonella enterica. Genetics [Internet] 2004; 168:1787–1794. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15611156
   PubMed Web of Science ®Google Scholar
• Prieto AI, Ramos-Morales F, Casadesús J. Repair of DNA damage induced by bile salts in Salmonella enterica. Genetics [Internet] 2006; 174:575–584. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16888329
   PubMed Web of Science ®Google Scholar
• Hernández SB, Cota I, Ducret A, Aussel L, Casadesús J. Adaptation and preadaptation of Salmonella enterica to Bile. PLoS Genet [Internet] 2012; 8:e1002459. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22275872
   PubMed Web of Science ®Google Scholar
• Rodríguez-Beltrán J, Rodríguez-Rojas A, Guelfo JR, Couce A, Blázquez J. The Escherichia coli SOS gene dinF protects against oxidative stress and bile salts. PLoS One [Internet] 2012; 7:e34791. Available from http://www.ncbi.nlm.nih.gov/pubmed/22523558.
   PubMed Web of Science ®Google Scholar
• Walawalkar YD, Vaidya Y, Nayak V. Response of Salmonella Typhi to bile-generated oxidative stress: implication of quorum sensing and persister cell populations. Pathog Dis. [Internet] 2016; 74. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27609462
   PubMed Web of Science ®Google Scholar
• Hung DT, Zhu J, Sturtevant D, Mekalanos JJ. Bile acids stimulate biofilm formation in Vibrio cholerae. Mol Microbiol [Internet] 2006; 59:193–201. Available from: https://onlinelibrary.wiley.com/doi/10.1111/j.1365-2958.2005.04846.x
   PubMed Web of Science ®Google Scholar
• Dubois T, Tremblay YDN, Hamiot A, Martin-Verstraete I, Deschamps J, Monot M, Briandet R, Dupuy B. A microbiota-generated bile salt induces biofilm formation in Clostridium difficile. NPJ Biofilms Microbiomes [Internet] 2019; 5:14.Available from: http://www.ncbi.nlm.nih.gov/pubmed/31098293
   PubMed Web of Science ®Google Scholar
• Pumbwe L, Skilbeck CA, Nakano V, Avila-Campos MJ, Piazza RMF, Wexler HM. Bile salts enhance bacterial co-aggregation, bacterial-intestinal epithelial cell adhesion, biofilm formation and antimicrobial resistance of Bacteroides fragilis. Microb Pathog [Internet] 2007; 43:78–87. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0882401007000472
   PubMed Web of Science ®Google Scholar
• Kelly SM, Lanigan N, O’Neill IJ, Bottacini F, Lugli GA, Viappiani A, Turroni F, Ventura M, van Sinderen D. Bifidobacterial biofilm formation is a multifactorial adaptive phenomenon in response to bile exposure. Sci Rep [Internet] 2020; 10:11598. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32665665
   PubMed Web of Science ®Google Scholar
• Hay AJ, Zhu J. Host intestinal signal-promoted biofilm dispersal induces Vibrio cholerae colonization. Infect Immun [Internet] 2015; 83:317–323. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25368110
   PubMed Web of Science ®Google Scholar
• Darfeuille-Michaud A, Boudeau J, Bulois P, Neut C, Glasser A-L, Barnich N, Bringer M-A, Swidsinski A, Beaugerie L, Colombel J-F. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease. Gastroenterology [Internet] 2004; 127:412–421. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15300573
   PubMed Web of Science ®Google Scholar
• Ormsby MJ, Johnson SA, Carpena N, Meikle LM, Goldstone RJ, McIntosh A, Wessel HM, Hulme HE, McConnachie CC, Connolly JPR, et al. Propionic Acid promotes the virulent phenotype of Crohn’s disease-associated adherent-invasive Escherichia coli. Cell Rep [Internet] 2020; 30:2297–2305. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32075765
   PubMed Web of Science ®Google Scholar
• Rolhion N, Carvalho FA, Darfeuille-Michaud A. OmpC and the sigma(E) regulatory pathway are involved in adhesion and invasion of the Crohn’s disease-associated Escherichia coli strain LF82. Mol Microbiol [Internet] 2007; 63:1684–1700. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17367388
   PubMed Web of Science ®Google Scholar
• Lucchini V, Sivignon A, Pieren M, Gitzinger M, Lociuro S, Barnich N, Kemmer C, Trebosc V. The role of OmpR in bile tolerance and pathogenesis of adherent-invasive Escherichia coli. Front Microbiol [Internet] 2021; 12. Available from: https://www.frontiersin.org/articles/10.3389/fmicb.2021.684473/full
   Google Scholar
• Johnson R, Ravenhall M, Pickard D, Dougan G, Byrne A, Frankel G. Comparison of Salmonella enterica Serovars Typhi and Typhimurium Reveals Typhoidal Serovar-Specific Responses to Bile. Infect Immun. [Internet] 2018; 86. Available from:.http://www.ncbi.nlm.nih.gov/pubmed/29229736
   Web of Science ®Google Scholar
• Eade CR, Hung C-C, Bullard B, Gonzalez-Escobedo G, Gunn JS, Altier C. Bile acids function synergistically to repress invasion gene expression in Salmonella by destabilizing the invasion regulator hilD. Infect Immun [Internet] 2016; 84:2198–2208. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27185788
   PubMed Web of Science ®Google Scholar
• Yang M, Liu Z, Hughes C, Stern AM, Wang H, Zhong Z, Kan B, Fenical W, Zhu J. Bile salt-induced intermolecular disulfide bond formation activates Vibrio cholerae virulence. Proc Natl Acad Sci U S A [Internet] 2013; 110:2348–2353. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23341592
   PubMed Web of Science ®Google Scholar
• Gupta S, Chowdhury R. Bile affects production of virulence factors and motility of Vibrio cholerae. Infect Immun [Internet] 1997; 65:1131–1134. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9038330
   PubMed Web of Science ®Google Scholar
• Barton LL, Ritz NL, Fauque GD, Lin HC. Sulfur cycling and the intestinal microbiome. Dig Dis Sci [Internet] 2017; 62:2241–2257. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28766244
   PubMed Web of Science ®Google Scholar
• Forte E, Borisov VB, Falabella M, Colaço HG, Tinajero-Trejo M, Poole RK, Vicente JB, Sarti P, Giuffrè A. The terminal oxidase cytochrome bd promotes sulfide-resistant bacterial respiration and growth. Sci Rep [Internet] 2016; 6:23788. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27030302
   PubMed Web of Science ®Google Scholar
• Lopez CA, Miller BM, Rivera-Chávez F, Velazquez EM, Byndloss MX, Chávez-Arroyo A, Lokken KL, Tsolis RM, Winter SE, Bäumler AJ. Virulence factors enhance Citrobacter rodentium expansion through aerobic respiration. Science [Internet] 2016; 353:1249–1253. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27634526
   PubMed Web of Science ®Google Scholar
• Suarez FL, Furne JK, Springfield J, Levitt MD. Bismuth subsalicylate markedly decreases hydrogen sulfide release in the human colon. Gastroenterology [Internet] 1998; 114:923–929. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9558280.
   PubMedGoogle Scholar
• Jia W, Xie G, Jia W. Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis. Nat Rev Gastroenterol Hepatol [Internet] 2018; 15:111–128. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29018272
   PubMed Web of Science ®Google Scholar
• Zhang Y-Z, Li Y-Y. Inflammatory bowel disease: pathogenesis. World J Gastroenterol [Internet] 2014; 20:91–99. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24415861
   PubMed Web of Science ®Google Scholar
• Tiratterra E. Role of bile acids in inflammatory bowel disease. Ann Gastroenterol [Internet] 2018; 31:266–272. Available from: http://www.annalsgastro.gr/files/journals/1/earlyview/2018/ev-02-2018-08-AG3388-REV-0239.pdf
   PubMed Web of Science ®Google Scholar
• Vantrappen G, Ghoos Y, Rutgeerts P, Janssens J. Bile acid studies in uncomplicated Crohn’s disease. Gut [Internet] 1977; 18:730–735. Available from: http://www.ncbi.nlm.nih.gov/pubmed/604194
   PubMed Web of Science ®Google Scholar
• Rutgeerts P, Ghoos Y, Vantrappen G. Kinetics of primary bile acids in patients with non-operated Crohn’s disease. Eur J Clin Invest [Internet] 1982; 12:135–143. Available from: http://www.ncbi.nlm.nih.gov/pubmed/6807684
   PubMed Web of Science ®Google Scholar
• Gothe F, Beigel F, Rust C, Hajji M, Koletzko S, Freudenberg F. Bile acid malabsorption assessed by 7 alpha-hydroxy-4-cholesten-3-one in pediatric inflammatory bowel disease: correlation to clinical and laboratory findings. J Crohns Colitis [Internet] 2014; 8:1072–1078. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24666974
   PubMed Web of Science ®Google Scholar
• Nyhlin H, Merrick M, Eastwood MA. Bile acid malabsorption in Crohn’s disease and indications for its assessment using SeHCAT. Gut [Internet] 1994; 35:90–93. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8307458
   PubMed Web of Science ®Google Scholar
• Lenicek M, Duricova D, Komarek V, Gabrysova B, Lukas M, Smerhovsky Z, Vitek L. Bile acid malabsorption in inflammatory bowel disease: assessment by serum markers. Inflamm Bowel Dis [Internet] 2011; 17:1322–1327. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21058331.
   PubMed Web of Science ®Google Scholar
• Morgan XC, Tickle TL, Sokol H, Gevers D, Devaney KL, Ward D, Reyes JA, Shah SA, LeLeiko N, Snapper SB, et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol [Internet] 2012; 13:R79.Available from: http://www.ncbi.nlm.nih.gov/pubmed/23013615
   PubMed Web of Science ®Google Scholar
• Byndloss MX, Bäumler AJ. The germ-organ theory of non-communicable diseases. Nat Rev Microbiol [Internet] 2018; 16:103–110. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29307890
   PubMed Web of Science ®Google Scholar
• Winter SE, Lopez CA, Bäumler AJ. The dynamics of gut-associated microbial communities during inflammation. EMBO Rep [Internet] 2013; 14:319–327. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23478337
   PubMed Web of Science ®Google Scholar
• Byndloss MX, Pernitzsch SR, Bäumler AJ. Healthy hosts rule within: ecological forces shaping the gut microbiota. Mucosal Immunol [Internet] 2018; 11:1299–1305. Available from: https://www.nature.com/articles/s41385-018-0010-y
   PubMed Web of Science ®Google Scholar
• Mullish BH, Allegretti JR. The contribution of bile acid metabolism to the pathogenesis of Clostridioides difficile infection. Therap Adv Gastroenterol [Internet] 2021; 14:175628482110177. Available from: http://journals.sagepub.com/doi/10.1177/17562848211017725
   Web of Science ®Google Scholar
• Panzitt K, Zollner G, Marschall H-U, Wagner M. Recent advances on FXR-targeting therapeutics. Mol Cell Endocrinol [Internet] 2022; 552:111678. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0303720722001265
   PubMed Web of Science ®Google Scholar
• Hodge RJ, Nunez DJ. Therapeutic potential of Takeda-G-protein-receptor-5 (TGR5) agonists. Hope or hype? Diabetes Obes Metab [Internet] 2016; 18:439–443. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26818602
   PubMed Web of Science ®Google Scholar